Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2008 1
2009 1
2010 2
2011 2
2012 2
2013 3
2015 1
2018 2
2019 2
2020 6
2021 2
2022 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
Resectable Colorectal Cancer: Current Perceptions on the Correlation of Recurrence Risk, Microbiota and Detection of Genetic Mutations in Liquid Biopsies.
Koulouris A, Tsagkaris C, Messaritakis I, Gouvas N, Sfakianaki M, Trypaki M, Spyrou V, Christodoulakis M, Athanasakis E, Xynos E, Tzardi M, Mavroudis D, Souglakos J. Koulouris A, et al. Among authors: sfakianaki m. Cancers (Basel). 2021 Jul 14;13(14):3522. doi: 10.3390/cancers13143522. Cancers (Basel). 2021. PMID: 34298740 Free PMC article. Review.
Prognostic Value of KRAS Mutations in Colorectal Cancer Patients.
Koulouridi A, Karagianni M, Messaritakis I, Sfakianaki M, Voutsina A, Trypaki M, Bachlitzanaki M, Koustas E, Karamouzis MV, Ntavatzikos A, Koumarianou A, Androulakis N, Mavroudis D, Tzardi M, Souglakos J. Koulouridi A, et al. Among authors: sfakianaki m. Cancers (Basel). 2022 Jul 7;14(14):3320. doi: 10.3390/cancers14143320. Cancers (Basel). 2022. PMID: 35884381 Free PMC article.
Investigation of Microbial Translocation, TLR and VDR Gene Polymorphisms, and Recurrence Risk in Stage III Colorectal Cancer Patients.
Messaritakis I, Koulouridi A, Boukla E, Sfakianaki M, Vogiatzoglou K, Karagianni M, Gouvas N, Tsiaoussis J, Xynos E, Athanasakis E, Mavroudis D, Tzardi M, Souglakos J. Messaritakis I, et al. Among authors: sfakianaki m. Cancers (Basel). 2022 Sep 10;14(18):4407. doi: 10.3390/cancers14184407. Cancers (Basel). 2022. PMID: 36139567 Free PMC article.
The Role of Vitamin D Receptor Gene Polymorphisms in Colorectal Cancer Risk.
Messaritakis I, Koulouridi A, Sfakianaki M, Vogiatzoglou K, Gouvas N, Athanasakis E, Tsiaoussis J, Xynos E, Mavroudis D, Tzardi M, Souglakos J. Messaritakis I, et al. Among authors: sfakianaki m. Cancers (Basel). 2020 May 27;12(6):1379. doi: 10.3390/cancers12061379. Cancers (Basel). 2020. PMID: 32471257 Free PMC article.
Prognostic significance of CEACAM5mRNA-positive circulating tumor cells in patients with metastatic colorectal cancer.
Messaritakis I, Sfakianaki M, Papadaki C, Koulouridi A, Vardakis N, Koinis F, Hatzidaki D, Georgoulia N, Kladi A, Kotsakis A, Souglakos J, Georgoulias V. Messaritakis I, et al. Among authors: sfakianaki m. Cancer Chemother Pharmacol. 2018 Nov;82(5):767-775. doi: 10.1007/s00280-018-3666-9. Epub 2018 Aug 9. Cancer Chemother Pharmacol. 2018. PMID: 30094617
Unraveling the Role of Molecular Profiling in Predicting Treatment Response in Stage III Colorectal Cancer Patients: Insights from the IDEA International Study.
Messaritakis I, Psaroudaki E, Vogiatzoglou K, Sfakianaki M, Topalis P, Iliopoulos I, Mavroudis D, Tsiaoussis J, Gouvas N, Tzardi M, Souglakos J. Messaritakis I, et al. Among authors: sfakianaki m. Cancers (Basel). 2023 Sep 30;15(19):4819. doi: 10.3390/cancers15194819. Cancers (Basel). 2023. PMID: 37835512 Free PMC article.
28 results